In a report released today, Yaron Werber from TD Cowen maintained a Buy rating on Ascendis Pharma (ASND – Research Report), with a price target ...

In its fourth quarter 2024 investor letter, Ariel Global Fund emphasized stocks such as CenterPoint Energy, Inc. (NYSE:CNP). CenterPoint Energy, Inc. (NYSE:CNP) is a US based public utility ...

For example, if you are using an x86_64 build of Windows, you would download the file named kubectl-cnp_<version>_windows_x86_64.tar.gz. The release includes a checksum file, named ...

Founded in 1997, and under the leadership of Terry Lynch, Transcon has developed significant ocean import business from the transpacific including buyer consolidation services, less-than-container ...

Founded in 1997, and under the leadership of Terry Lynch, Transcon has developed significant ocean import business from the transpacific including buyer consolidation services, less-than-container ...

Ascendis Pharma (ASND) reported its fourth-quarter 2024 earnings, highlighting a significant revenue increase and a positive market reaction. The company posted total revenue of €173.9 million for the ...

“This marks another step toward – YORVIPATH launching in U.S. with product availability expected mid-January 2025; ex-U.S. YORVIPATH revenue of €8.5 million in Q3 – TransCon CNP NDA ...

The potential upside from other products like Yorvipath and TransCon CNP is seen as a counterbalance to Skytrofa’s current underperformance. Ascendis Pharma’s pipeline includes TransCon CNP, a ...